Cross-discipline team publishes on Cr(VI) in air
A team of ToxStrategies and EpidStrategies scientists are authors on a manuscript being published in Regulatory Toxicology and Pharmacology. The study examines current… read more
Latest News
EpidStrategies participating in European Hematology Association 2021
EpidStrategies, a division of ToxStrategies, Inc., is excited to be participating in the European Hematology Association Virtual Congress, which will be held virtually from… read more
ToxStrategies Welcomes John M. Rogers, Ph.D.
ToxStrategies is pleased to announce that John M. Rogers, Ph.D., has joined our Health Sciences Practice, following a distinguished career with the U.S…. read more
New RSV article accepted by The Journal of Pediatrics
Ms. Mina Suh, along with colleagues within EpidStrategies (a Division of ToxStrategies), and external collaborators, has been conducting research on respiratory syncytial virus (RSV), especially as it relates to infants and children in the United States. In a prospective viral surveillance study, which was recently accepted… read more
EpidStrategies Scientist on Leadership Panel
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
EpidStrategies and ToxStrategies review essential elements for a successful orphan drug program
EpidStrategies scientists have collaborated with toxicologists from ToxStrategies’ Biopharmaceuticals/Pharmaceuticals Practice to produce a white paper that provides “Critical insights into nonclinical toxicology and… read more
New opening for an Epidemiologist
EpidStrategies, a division of ToxStrategies, Inc., has opened a position for an epidemiologist to join our team of epidemiologists and statisticians conducting systematic… read more